irinotecan has been researched along with Colitis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Broudin, C; Gallois, C; Jenvrin, A; Palmieri, LJ; Perret, A; Rance, B; Soularue, E; Taieb, J | 1 |
| Chen, X; Han, W; Li, Y; Shi, L; Wan, J; Wang, H; Xie, B | 1 |
| Du, GH; Wang, L; Wang, R; Wang, SM; Wang, Z; Wei, GY; Zhang, RP; Zhu, Y | 1 |
| Chen, YY; Duan, JA; Jiang, JQ; Kang, A; Qin, YF; Tang, YP; Tao, HJ; Yue, SJ; Zhou, GS | 1 |
| He, W; Lan, L; Li, M; Liu, D; Ren, X; Xiang, D; Xu, Y; Zhang, C; Zhang, S | 1 |
| Matsui, H; Nagasaki, Y; Vong, LB; Yoshitomi, T | 1 |
| Bateman, E; Keefe, D; Klein, G; Mayo, B; Plews, E; Weaver, E; White, I; Wignall, A; Wozniak, B | 1 |
| Gu, Y; Li, L; Li, Q; Wang, W; Wu, X; Xu, Q; Zhang, X | 1 |
| Casey, DA; Chou, AJ; Merchant, MS; Merola, PR; Meyers, PA; Price, AP; Wexler, LH | 1 |
| Deepak, P; Ehrenpreis, ED | 1 |
| Beatrix, O; Dumortier, J; Lapalus, MG; Lombard-Bohas, C; Scoazec, JY; Villarejo, J; Vochelle, V | 1 |
| Bouzourene, H; Chaubert, P; Sandmeier, D | 1 |
| Avery, R; Bachinski, MS; McNally, P; Sears, S | 1 |
2 review(s) available for irinotecan and Colitis
| Article | Year |
|---|---|
Diarrhea.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Colitis; Colon; Colonoscopy; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Enterocolitis, Pseudomembranous; Gastrointestinal Motility; Humans; Irinotecan; Muscle Contraction; Sodium-Potassium-Exchanging ATPase; Steatorrhea | 2011 |
Irinotecan (CPT-11) induced colitis: report of a case and review of Food and Drug Administration MEDWATCH reporting.
Topics: Adenocarcinoma; Adverse Drug Reaction Reporting Systems; Antineoplastic Agents, Phytogenic; Camptothecin; Chemotherapy, Adjuvant; Colitis; Colonoscopy; Female; Gastrointestinal Hemorrhage; Humans; Intestinal Mucosa; Irinotecan; Liver Neoplasms; Middle Aged; Neoplasm Staging; Sigmoid Neoplasms; United States; United States Food and Drug Administration | 1999 |
1 trial(s) available for irinotecan and Colitis
| Article | Year |
|---|---|
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Camptothecin; Child; Child, Preschool; Colitis; Dacarbazine; Diarrhea; Female; Humans; Irinotecan; Male; Neutropenia; Pneumonia; Recurrence; Remission Induction; Retrospective Studies; Sarcoma, Ewing; Temozolomide; Thrombocytopenia; Young Adult | 2009 |
10 other study(ies) available for irinotecan and Colitis
| Article | Year |
|---|---|
Chemotherapy-induced ileitis associated or not with colitis in digestive oncology patients: An AGEO multicentre study.
Topics: Antineoplastic Agents; Colitis; Diarrhea; Humans; Ileitis; Irinotecan; Neoplasms | 2023 |
Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer.
Topics: Administration, Oral; Animals; Apoptosis; Azoxymethane; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colitis; Colorectal Neoplasms; Curcumin; Cytokines; Dextran Sulfate; Disease Models, Animal; Disease Progression; Drug Synergism; Female; Inflammation; Inflammation Mediators; Intestines; Irinotecan; Macrophages; Mice; Mice, Inbred C57BL; Nanoparticles; RAW 264.7 Cells | 2019 |
Cryptotanshinone alleviates chemotherapy-induced colitis in mice with colon cancer via regulating fecal-bacteria-related lipid metabolism.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Bacteria; Colitis; Colon; Colonic Neoplasms; Feces; Fluorouracil; Gastrointestinal Microbiome; Irinotecan; Lipid Metabolism; Male; Mice, Inbred BALB C; Phenanthrenes; RNA, Ribosomal, 16S | 2021 |
Total Flavonoids of
Topics: Animals; Anti-Inflammatory Agents; Bacteria; Colitis; Colon; Cytokines; Disease Models, Animal; Dysbiosis; Feces; Flavonoids; Gastrointestinal Microbiome; Glycyrrhiza uralensis; Inflammasomes; Inflammation Mediators; Irinotecan; Male; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Plant Extracts | 2021 |
IL-6 downregulates hepatic carboxylesterases via NF-κB activation in dextran sulfate sodium-induced colitis.
Topics: Alanine Transaminase; Animals; Antibodies; Aspartate Aminotransferases; C-Reactive Protein; Carboxylesterase; Carboxylic Ester Hydrolases; Cell Line; Clopidogrel; Colitis; Colon; Cytokines; Dextran Sulfate; Humans; Irinotecan; Liver; Male; Mice, Inbred C57BL; Microsomes, Liver; NF-kappa B; Peroxidase; Platelet Aggregation Inhibitors; Topoisomerase I Inhibitors | 2021 |
Development of an oral nanotherapeutics using redox nanoparticles for treatment of colitis-associated colon cancer.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Azoxymethane; Camptothecin; Cell Line, Tumor; Colitis; Colonic Neoplasms; Dextrans; Drug Delivery Systems; Drug Screening Assays, Antitumor; Endoscopy; Free Radical Scavengers; Inflammation; Irinotecan; Male; Mice; Mice, Inbred ICR; Nanomedicine; Nanoparticles; Neoplasms, Experimental; Nitrogen Oxides; Oxidation-Reduction; Reactive Oxygen Species; Sulfates | 2015 |
Serum-derived bovine immunoglobulin/protein isolate in the alleviation of chemotherapy-induced mucositis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Blood Proteins; Body Weight; Camptothecin; Cattle; Colitis; Diarrhea; Enteritis; Female; Immunoglobulins; Injections, Intraperitoneal; Irinotecan; Jejunal Diseases; Mucositis; Random Allocation; Rats | 2016 |
CPT-11 activates NLRP3 inflammasome through JNK and NF-κB signalings.
Topics: Animals; Anti-Inflammatory Agents; Camptothecin; Carrier Proteins; Caspase 1; Cell Line, Tumor; Colitis; Colon; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; Inflammation Mediators; Interleukin-1beta; Interleukin-8; Irinotecan; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophages; Mice, Inbred C57BL; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Permeability; Protein Kinase Inhibitors; Signal Transduction; Time Factors; Topoisomerase I Inhibitors | 2015 |
[Severe acute cytomegalovirus colitis after administration of irinotecan and raltitrexed chemotherapy].
Topics: Acute Disease; Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Camptothecin; Colitis; Cytomegalovirus Infections; Ganciclovir; Humans; Immunocompromised Host; Irinotecan; Male; Quinazolines; Rectal Neoplasms; Sigmoid Neoplasms; Thiophenes | 2003 |
Irinotecan-induced colitis.
Topics: Aged; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers; Biopsy; Brain Neoplasms; Camptothecin; Colitis; Colon; Diarrhea; Glioblastoma; Humans; Ileum; Immunoenzyme Techniques; Irinotecan; Male; Topoisomerase I Inhibitors | 2005 |